Skip to main content

TFC Financial Management, Inc.

Position in CRSP — CRISPR Therapeutics AG

CIK 1827844 BOSTON, MA

Position in CRSP

as of Jun 30, 2026 · filed Jul 23, 2026
Position Value
$33,814
+$1,086 QoQ
Shares Held
620
-9.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#366
of 519 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in CRSP Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

TFC Financial Management, Inc. holds $462,229 across 45 Biotechnology names. CRSP ranks #4 (7.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 CRSP
CRISPR Therapeutics AG
This page
620 $33,814

All Filings in CRSP

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $33,814 620
2026-03-31 $32,728 688
2025-12-31 $36,078 688
2025-09-30 $44,589 688
2025-06-30 $34,923 718
2025-03-31 $24,433 718
2024-12-31 $26,686 678
2024-09-30 $35,610 758
2024-06-30 $37,807 700
2024-03-31 $47,712 700
2023-12-31 $43,820 700
2023-09-30 $907 20
2023-06-30 $1,122 20
2023-03-31 $904 20
2022-12-31 $813 20
2022-09-30 $1,307 20
2022-06-30 $1,215 20
2022-03-31 $1,255 20
2021-12-31 $21,900 289
2021-09-30 $32,347 289
2021-06-30 $46,786 289
2021-03-31 $35,214 289
2020-12-31 $44,248 289
2020-09-30 $22,499 269